Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The OUCAGS Research Elective Bursary is a competitive award for Oxford medical students. Its 2016-17 scheme has made 15 awards to students wishing to undertake a research project during either their first or second elective period.

Awardees received up to £2,000 to facilitate projects that consolidate their previous research experience, or explore an area of research that may be of future interest to them. Projects are in a range of subject areas and many are based outside of the UK (see below).

The OUCAGS Research Elective Bursary is an annual scheme which makes awards to candidates who show evidence of a genuine and sustained interest in biomedical research. Funds can be used towards a combination of travel and subsistence, bench fees and consumables (for lab-based projects), registration fees and health insurance expenses. Calls for applications to the scheme are advertised on the OUCAGS website. The next round is expected to open in summer 2017.

2016-17 bursary recipients include (name, project title, host institution):

  • Budge, E  ‘Elonva Flare’: a novel stimulation protocol for poor responders. University of New South Wales, Sydney, Australia
  • Callanan, E  Title to be confirmed. Kenyan Medical Research Institute, Kilifi
  • Cotton, N  Brain imaging in the major psychoses: examining structural and functional connectivity. The University of Iowa Carver College of Medicine
  • Dumann, E  An audit into the optimal management of peritoneal dialysis patients – infection control and fluid status. Klinikum St Elisabeth Straubing GmbH
  • Elangovan, R  Genetic analysis in very early-onset inflammatory bowel disease (VEO-IBD). Children's Hospital of Philadelphia
  • Farrar, C  Molecular regulation of angiogenesis by protease-activated receptors (PARs): differential utilisation of cyclooxygenase-2 (COX-2) and peroxisome proliferator-activated receptor (PPAR) b/d.  National Heart and Lung Institute, Imperial College London / Royal Veterinary College
  • Kemp, R  Role of approval pathway in the approval of drugs by the US food and drug administration. Knight Cancer Institute, Oregon Health Science University
  • McGillivray, C  The identification of somatic mutations in patients with congenital vascular malformations. Warman Lab, Boston Children's Hospital & Harvard Medical School
  • Redfern, A Cost-effectiveness of a parenting programme for the prevention of abuse of adolescents in South Africa. Department of Social Policy and Evidence-Based Intervention, University of Oxford
  • Takata, J  Cost of antimicrobial resistance in Cambodia. Cambodia-Oxford Medical Research Unit (COMRU), Angkor, and Mahidol-Oxford Research Unit, Bangkok